American Society of Clinical Oncology

SHERPA: White

People

  1. Scher
    Scher
  2. Motzer
    Motzer
  3. Bajorin
    Bajorin
  4. Hudis
    Hudis
  5. Kris
    Kris
  6. Saltz
    Saltz
  7. Kelsen
    Kelsen
  8. Morris
    Morris
  9. Aghajanian
    Aghajanian
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (232)
  2. Solid Tumor Oncology Division (193)
  3. Survivorship Research (76)
  4. Epidemiology and Biostatistics (71)
  5. Genitourinary Oncology Service (62)
  6. Surgery (62)
  7. Biostatistics Service (58)
  8. GSK Faculty (48)
  9. Gastrointestinal Oncology Service (43)
  10. Breast Medicine Service (41)
Search Within
  1. "2011"
Formats
  1. Meeting Abstract (239)
  2. Journal Article (88)
Groups
  1. Department of Medicine (232)
  2. Solid Tumor Oncology Division (193)
  3. Survivorship Research (76)
  4. Epidemiology and Biostatistics (71)
  5. Genitourinary Oncology Service (62)
  6. Surgery (62)

More Groups

People
  1. Howard Scher (23)
  2. Robert Motzer (18)
  3. Sujata Patil (17)
  4. Clifford Hudis (14)
  5. Dean Bajorin (14)
  6. Mark Kris (14)

More People

Years
  1. 2011 (327)
Publications
  1. Journal of Clinical Oncology (319)
  2. Journal of Oncology Practice (8)

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of hereditary GIST susceptibility in adults with GIST
    Meeting Abstract

    Rainville, I. R.; Root, E. J.; Salerno, M.; DiGianni, L.; Nelson, D. A.; Corless, C. L.; Heinrich, M. C.; Robson, M. E.; Garber, J. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • AMC075: A sequential phase I/randomized phase II trial of vorinostat and risk-adapted chemotherapy with rituximab in HIV-related B-cell non-Hodgkin's lymphoma
    Meeting Abstract

    Ramos, J. C.; Sparano, J. A.; Moore, P. C.; Ambinder, R. F.; Noy, A.; Mitsuyasu, R. T.; AIDS Malignancy Consortium
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical, pathologic, and molecular characteristics of patients with non-small cell lung cancer harboring mutations in PIK3CA
    Meeting Abstract

    Pietanza, M. C.; Arcila, M. E.; Chaft, J. E.; Zakowski, M. F.; Ladanyi, M.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Methotrexate (MTX) rechallenge for recurrent primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Pentsova, E.; DeAngelis, L. M.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • CT-guided radiofrequency ablation in the management of pulmonary colorectal metastases
    Meeting Abstract

    Petre, E. N.; Jia, X.; Sofocleous, C. T.; Thornton, R. H.; Alago, W.; Kemeny, N. E.; Solomon, S. B.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR)
    Meeting Abstract

    Pennell, N. A.; Neal, J. W.; Govindan, R.; Janne, P. A.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Lanuti, M.; Azzoli, C. G.; Sequist, L. V.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Treatment of cervical intraepithelial neoplasia with topical imiquimod
    Meeting Abstract

    Polterauer, S.; Grimm, C.; Natter, C.; Rahhal, J.; Hefler, L.; Reinthaller, A.; Speiser, P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Analysis of the relationship between Karnofsky performance status (KPS) and tumor response in the RECORD-1 phase III trial of everolimus in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Porta, C.; Escudier, B.; Hutson, T. E.; Figlin, R. A.; Calvo, E.; Grünwald, V.; Osanto, S.; Ravaud, A.; Panneerselvam, A.; Knox, J. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Meeting Abstract

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save